These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Measuring drug effectiveness by default: the case of Bendectin. Neutel CI; Johansen HL Can J Public Health; 1995; 86(1):66-70. PubMed ID: 7728721 [TBL] [Abstract][Full Text] [Related]
27. Bendectin and fetal malformations. Pearson RD Can Med Assoc J; 1981 Feb; 124(3):259. PubMed ID: 7459786 [No Abstract] [Full Text] [Related]
28. More on Bendectin. MacMahon B JAMA; 1981 Jul 24-31; 246(4):371-2. PubMed ID: 7241787 [No Abstract] [Full Text] [Related]
29. Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: I. Norethisterone acetate + ethinylestradiol and progesterone + estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus). Hendrickx AG; Korte R; Leuschner F; Neumann BW; Prahalada S; Poggel A; Binkerd PE; Günzel P Teratology; 1987 Feb; 35(1):119-27. PubMed ID: 3563930 [TBL] [Abstract][Full Text] [Related]
30. Drug therapy in pregnancy: the lessons of diethylstilbestrol, thalidomide, and bendectin. Saunders EJ; Saunders JA Health Care Women Int; 1990; 11(4):423-32. PubMed ID: 2228814 [TBL] [Abstract][Full Text] [Related]
32. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing. Webster WS; Brown-Woodman PD; Ritchie HE Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342 [TBL] [Abstract][Full Text] [Related]
33. Transvaginal ultrasonographic (TVS) evaluation of baboon gestation from 37-62 days postconception. Santolaya-Forgas J; Vengalil S; Meyer W; Fortman J Am J Primatol; 1997; 43(4):323-8. PubMed ID: 9403096 [TBL] [Abstract][Full Text] [Related]
35. Nonhuman primates: their role in assessing developmental effects of immunomodulatory agents. Hendrickx AG; Makori N; Peterson P Hum Exp Toxicol; 2000 Apr; 19(4):219-25. PubMed ID: 10918511 [TBL] [Abstract][Full Text] [Related]
36. Admissibility of scientific testimony into evidence. Brushwood DB Am J Hosp Pharm; 1994 Mar; 51(5):683-5. PubMed ID: 8203391 [No Abstract] [Full Text] [Related]
37. The state and future requirements of teratogenic testing. Wendler D Arch Toxicol Suppl; 1980; 4():274-83. PubMed ID: 6933916 [TBL] [Abstract][Full Text] [Related]
38. The innocent bystander. Doxylamine/dicyclomine/pyridoxine and congenital limb defects. McCredie J; Kricker A; Elliott J; Forrest J Med J Aust; 1984 Apr; 140(9):525-7. PubMed ID: 6708895 [TBL] [Abstract][Full Text] [Related]
39. Developmental toxicology - an integral part of safety evaluation of new drugs. Ujházy E; Mach M; Dubovický M; Navarová J; Brucknerová I Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):209-12. PubMed ID: 16601757 [TBL] [Abstract][Full Text] [Related]
40. Developmental staging and thalidomide teratogenicity in the green monkey (Cercopithecus aethiops). Hendrickx AG; Sawyer RH Teratology; 1978 Dec; 18(3):393-404. PubMed ID: 105418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]